Based on these data, we demonstrated that mutations in the prolyl-3-hydroxylation complex, causing the synthesis of overmodified collagen, lead to the disruption of ER homeostasis and consequent activation of the PERK branch of the UPR in OI fibroblasts. The gene discussed is EIF2AK3; the disease is osteogenesis imperfecta.